How do researchers optimize the use of new infrastructure? They look very hard at the human fit.
Investigators at the Research Institute of the McGill University Health Centre (RI-MUHC) formed new interdisciplinary research programs in 2015. Each researcher is, moreover, associated with at least one of our three RI-MUHC centres. Concentrating methodological expertise, each centre unites researchers from all eight programs and offers a gateway to creativity and innovation.
Centre for Innovative Medicine (CIM)
Director: Dr. Jean Bourbeau
Contact: CIM Team
Clinicians and clinician scientists at the RI-MUHC benefit from one of the most modern research facilities in North America, helping them develop and evaluate new treatments for some of the world’s most critical diseases. Strategically positioned within the MUHC at the Glen site, the Centre for Innovative Medicine (CIM) began offering services in fall 2015 and launched officially in spring 2016. Researchers have access to a full range of services in a state-of-the-art environment dedicated to clinical research, including project management of multicentre trials, quality control monitoring, clinical data management and statistical analysis. The CIM offers researchers facilities to carry out their clinical research and access to equipment dedicated solely to research: physiology platforms, a medical imaging platform, surgery facility and more.
Contact: CORE manager, Dr. Dominique J. Favreau
(514-934-1934 ext. 45493)
Created in 2013, the Centre for Outcomes Research and Evaluation (CORE) comprises a team of 85 RI-MUHC investigators and more than 350 trainees and professional staff focused on epidemiologic, biostatistical and health services research. Their approach to science uses rigorous research designs of exposed and non-exposed (control) groups and biostatistical analyses to infer cause-and-effect relationships between exposure and outcome. Their training includes the design, conduct and analysis of randomized controlled trials, observational (non-experimental) studies, and diagnostic test evaluations. These studies often involve recruiting large groups of participants or the use of population and health services databases. Other CORE members use qualitative research methods to investigate the “why” behind beliefs, attitudes and practices among the general population, health care practitioners and policy makers.
Using large data sets from a range of government and medical sources, CORE researchers assess the health impact of new treatments, nutrition and environmental factors. Their work also increases our understanding of the causes and treatments of a wide spectrum of diseases, including cancer, cardiovascular disease and respiratory disorders.
CORE researchers and personnel moved into new headquarters adjacent to the Glen site in 2017, and within the next year or two will occupy additional space undergoing renovation at the Montreal General Hospital of the MUHC.
Director: Dr. Don van Meyel
At the Centre for Translational Biology (CTB), approximately 150 researchers and their teams conduct fundamental research into essential cellular and metabolic processes, and study how these processes are disturbed in diseases. They use a wide range of models and interdisciplinary approaches to understand the many factors contributing to human health. The CTB houses technology platforms that provide access to state-of-the-art equipment and services for bioinformatics, histopathology, immunophenotyping, biobanking, proteomics, pathogen research, drug development, microscopy and other forms of imaging within tissues. The technology platforms facilitate collaboration among researchers from distinct disciplines, and they offer training for students and staff that is the basis of an academic health centre and a key driver of innovation. The CTB is located at both the Glen and Montreal General Hospital of the MUHC research sites.